Related Experiment Video
Updated: Jun 6, 2026
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Metformin for aging and cancer prevention
1Department of Carcinogenesis and Oncogerontology, N.N. Petrov Research Institute of Oncology, St. Petersburg 197758, Russia. aging@mail.ru
Aging
|November 19, 2010
Summary
Hyperglycemia and hyperinsulinemia are linked to aging. Antidiabetic drugs show promise for extending lifespan and preventing cancer by potentially modulating insulin/IGF-1 signaling pathways.
Area of Science:
- Gerontology and Cancer Research
Background:
- Hyperglycemia and hyperinsulinemia are implicated as key factors in the aging process.
- Insulin/insulin-like growth factor 1 (IGF-1) signaling pathways, including daf-2 and InR, are conserved across species and associated with longevity.
- Caloric restriction's life-prolonging effects may be mediated by reduced IGF-1 levels.
Purpose of the Study:
- To explore the potential of antidiabetic drugs in extending lifespan.
- To investigate the role of antidiabetic drugs in cancer prevention.
- To examine the impact of modulating insulin/IGF-1 signaling on aging and carcinogenesis.
Main Methods:
- Review of existing studies on mammals, nematodes, fruit flies, and mice.
- Analysis of evidence linking antidiabetic drugs to lifespan extension and cancer prevention.
- Examination of metformin's effect on cancer risk in diabetic patients.
Main Results:
- Inactivation of IGF-1 signaling genes (daf-2, InR) increases lifespan in model organisms.
- Antidiabetic drugs have demonstrated the ability to postpone spontaneous, chemical, and radiation-induced carcinogenesis in various animal models.
- Metformin use in diabetic patients is associated with a reduced risk of cancer.
Conclusions:
- Modulation of insulin/IGF-1 signaling is a potential target for lifespan extension and cancer prevention.
- Antidiabetic drugs represent a promising therapeutic strategy for both aging and cancer.
- Further research into antidiabetic agents could yield novel interventions for age-related diseases and cancer.
Related Concept Videos
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...